SAVERONE 2014 LTD -ADR (SVRE)

US80516T1051 - ADR

0.5599  -0.03 (-5.74%)

After market: 0.57 +0.01 (+1.8%)

Fundamental Rating

2

Overall SVRE gets a fundamental rating of 2 out of 10. We evaluated SVRE against 128 industry peers in the Electronic Equipment, Instruments & Components industry. SVRE has a bad profitability rating. Also its financial health evaluation is rather negative. SVRE is valued quite expensively, but it does show have an excellent growth rating.



1

1. Profitability

1.1 Basic Checks

SVRE had negative earnings in the past year.
In the past year SVRE has reported a negative cash flow from operations.
SVRE had negative earnings in each of the past 5 years.
SVRE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -125.36%, SVRE is doing worse than 95.24% of the companies in the same industry.
Looking at the Return On Equity, with a value of -320.04%, SVRE is doing worse than 94.44% of the companies in the same industry.
Industry RankSector Rank
ROA -125.36%
ROE -320.04%
ROIC N/A
ROA(3y)-113.03%
ROA(5y)-427.84%
ROE(3y)-211.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 27.65%, SVRE perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
In the last couple of years the Gross Margin of SVRE has grown nicely.
SVRE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.63%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

SVRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SVRE has more shares outstanding
Compared to 5 years ago, SVRE has more shares outstanding
Compared to 1 year ago, SVRE has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -8.85, we must say that SVRE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SVRE (-8.85) is worse than 95.24% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that SVRE is somewhat dependend on debt financing.
SVRE has a Debt to Equity ratio of 0.77. This is amonst the worse of the industry: SVRE underperforms 84.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z -8.85
ROIC/WACCN/A
WACC8.7%

2.3 Liquidity

A Current Ratio of 1.64 indicates that SVRE should not have too much problems paying its short term obligations.
SVRE has a Current ratio of 1.64. This is in the lower half of the industry: SVRE underperforms 71.43% of its industry peers.
A Quick Ratio of 1.33 indicates that SVRE should not have too much problems paying its short term obligations.
The Quick ratio of SVRE (1.33) is worse than 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.33

8

3. Growth

3.1 Past

SVRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.01%, which is quite impressive.
SVRE shows a strong growth in Revenue. In the last year, the Revenue has grown by 128.00%.
The Revenue has been growing by 104.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)35.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.44%
Revenue 1Y (TTM)128%
Revenue growth 3Y104.94%
Revenue growth 5YN/A
Sales Q2Q%53.51%

3.2 Future

Based on estimates for the next years, SVRE will show a very strong growth in Earnings Per Share. The EPS will grow by 32.21% on average per year.
SVRE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 155.66% yearly.
EPS Next Y53.79%
EPS Next 2Y32.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year162.94%
Revenue Next 2Y155.67%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SVRE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SVRE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SVRE's earnings are expected to grow with 32.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.21%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SVRE!.
Industry RankSector Rank
Dividend Yield N/A

SAVERONE 2014 LTD -ADR

NASDAQ:SVRE (5/28/2024, 7:00:01 PM)

After market: 0.57 +0.01 (+1.8%)

0.5599

-0.03 (-5.74%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.01M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -125.36%
ROE -320.04%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 27.65%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.64
Quick Ratio 1.33
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)35.01%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y53.79%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)128%
Revenue growth 3Y104.94%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y